YOUNG JAMES F
SEC CIK 1219864 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | Dir | 57.2K | — | $1.75M | 10 | 2021-07-01 | 2024-12-24 |
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
YOUNG JAMES F made no open-market trades at NVAX in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-02 | 2024-12-24+ | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | S - Sale | $8.22 | -10.0K | 57.2K | -15% | -$82.2K |
| 2024-06-25 | 2024-06-21 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | S - Sale | $14.09 | -7,500 | 61.8K | -11% | -$105.7K | |
| M | 2024-06-21 | 2024-06-18 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | S - Sale | $13.72 | -7,500 | 69.3K | -10% | -$102.9K |
| D | 2024-06-14 | 2024-06-12 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | M - OptEx | $0.00 | +6,670 | 76.8K | +10% | $0 |
| D | 2023-06-13 | 2023-06-10 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | M - OptEx | — | +4,600 | 68.6K | +7% | — |
| D | 2022-06-21 | 2022-06-17 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | M - OptEx | — | +1,400 | 64.0K | +2% | — |
| M | 2022-04-04 | 2022-03-31 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | S - Sale | $73.58 | -12.5K | 62.6K | -17% | -$919.8K |
| D | 2022-01-04 | 2021-12-31 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | M - OptEx | $25.60 | +3,750 | 78.8K | +5% | +$96.0K |
| D | 2022-01-04 | 2021-12-31 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | S - Sale+OE | $144.16 | -3,750 | 75.1K | -5% | -$540.6K |
| D | 2021-07-06 | 2021-07-01 | NVAX | NOVAVAX INC | YOUNG JAMES F | Dir | M - OptEx | — | +10.0K | 75.1K | +15% | — |
Purchase Sale Sale after option exercise All abbreviations